{
    "startDate": "2017-01-01",
    "endDate": "2017-06-30",
    "year": "2017",
    "quarter": "Q2",
    "symbol": "INO",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 23860637
            },
            {
                "label": "Short-term investments",
                "concept": "ShortTermInvestments",
                "unit": "usd",
                "value": 68138619
            },
            {
                "label": "Accounts receivable",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 7522548
            },
            {
                "label": "Accounts receivable from affiliated entity",
                "concept": "AccountsReceivableRelatedPartiesCurrent",
                "unit": "usd",
                "value": 1189300
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 4914764
            },
            {
                "label": "Prepaid expenses and other current assets from affiliated entity",
                "concept": "ino:PrepaidExpensesAndOtherCurrentAssetsFromAffiliatedEntity",
                "unit": "usd",
                "value": 1251730
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 106877598
            },
            {
                "label": "Fixed assets, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 15017992
            },
            {
                "label": "Investment in affiliated entity - GeneOne",
                "concept": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
                "unit": "usd",
                "value": 14612344
            },
            {
                "label": "Investment in affiliated entity - PLS",
                "concept": "CostMethodInvestmentsFairValueDisclosure",
                "unit": "usd",
                "value": 3339802
            },
            {
                "label": "Intangible assets, net",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 6817855
            },
            {
                "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 10513371
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 1674251
            },
            {
                "label": "ASSETS",
                "concept": "Assets",
                "unit": "usd",
                "value": 158853213
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "AccountsPayableAndAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 16477761
            },
            {
                "label": "Accounts payable and accrued expenses due to affiliated entity",
                "concept": "DueToRelatedPartiesCurrent",
                "unit": "usd",
                "value": 847421
            },
            {
                "label": "Accrued clinical trial expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 7188751
            },
            {
                "label": "Common stock warrants",
                "concept": "WarrantsAndRightsOutstanding",
                "unit": "usd",
                "value": 1363637
            },
            {
                "label": "Deferred revenue",
                "concept": "DeferredRevenueCurrent",
                "unit": "usd",
                "value": 548690
            },
            {
                "label": "Deferred revenue from affiliated entity",
                "concept": "ino:DeferredRevenueFromAffiliatedEntityCurrent",
                "unit": "usd",
                "value": 274194
            },
            {
                "label": "Deferred rent",
                "concept": "DeferredRentCreditCurrent",
                "unit": "usd",
                "value": 681544
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 27381998
            },
            {
                "label": "Deferred revenue, net of current portion",
                "concept": "DeferredRevenueNoncurrent",
                "unit": "usd",
                "value": 205938
            },
            {
                "label": "Deferred revenue from affiliated entity, net of current portion",
                "concept": "ino:DeferredRevenueFromAffiliatedEntityNoncurrent",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Deferred rent, net of current portion",
                "concept": "DeferredRentCreditNoncurrent",
                "unit": "usd",
                "value": 7560867
            },
            {
                "label": "Deferred tax liabilities",
                "concept": "DeferredTaxLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 174793
            },
            {
                "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 35323596
            },
            {
                "label": "Preferred stock",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Common stock",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 77634
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 589890620
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -467715568
            },
            {
                "label": "Accumulated other comprehensive income",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": 1180662
            },
            {
                "label": "Stockholders' Equity Note [Abstract]",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 123433348
            },
            {
                "label": "Non-controlling interest",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": 96269
            },
            {
                "label": "Inovio Pharmaceuticals, Inc. stockholders\u2019 equity:",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 123529617
            },
            {
                "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 158853213
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -32565023
            },
            {
                "label": "Depreciation",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 1020679
            },
            {
                "label": "Amortization of intangible assets",
                "concept": "AmortizationOfIntangibleAssets",
                "unit": "usd",
                "value": 810539
            },
            {
                "label": "Change in value of common stock warrants",
                "concept": "ino:ChangeInValueOfCommonStockWarrants",
                "unit": "usd",
                "value": 196023
            },
            {
                "label": "Award Type [Domain]",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 7937473
            },
            {
                "label": "Amortization of premiums on investments",
                "concept": "ino:InterestIncomeAccruedOnShortTermInvestmentsCertificatesOfDeposit",
                "unit": "usd",
                "value": 140599
            },
            {
                "label": "Loss on short-term investments",
                "concept": "GainLossOnInvestments",
                "unit": "usd",
                "value": -67366
            },
            {
                "label": "Deferred rent",
                "concept": "StraightLineRent",
                "unit": "usd",
                "value": -1869341
            },
            {
                "label": "Gain (loss) on investment in affiliated entity",
                "concept": "ino:ChangeInValueOfInvestmentsInAffiliatedCompany",
                "unit": "usd",
                "value": -1439721
            },
            {
                "label": "Gain on sale of intangible assets",
                "concept": "GainLossOnDispositionOfIntangibleAssets",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": -8298963
            },
            {
                "label": "Accounts receivable from affiliated entity",
                "concept": "IncreaseDecreaseInAccountsReceivableRelatedParties",
                "unit": "usd",
                "value": 440945
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 3165705
            },
            {
                "label": "Prepaid expenses and other current assets from affiliated entity",
                "concept": "ino:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssetsFromAffiliatedEntity",
                "unit": "usd",
                "value": -260694
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherOperatingAssets",
                "unit": "usd",
                "value": -438896
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": -4305114
            },
            {
                "label": "Accrued clinical trial expenses",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": 820362
            },
            {
                "label": "Accounts payable and accrued expenses due to affiliated entity",
                "concept": "IncreaseDecreaseInAccountsPayableRelatedParties",
                "unit": "usd",
                "value": -225158
            },
            {
                "label": "Deferred revenue",
                "concept": "IncreaseDecreaseInDeferredRevenue",
                "unit": "usd",
                "value": -14325900
            },
            {
                "label": "Deferred revenue from affiliated entity",
                "concept": "ino:IncreaseDecreaseInDeferredRevenueFromRelatedParties",
                "unit": "usd",
                "value": -219792
            },
            {
                "label": "Cash flows from operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -31946981
            },
            {
                "label": "Purchases of investments",
                "concept": "PaymentsToAcquireShortTermInvestments",
                "unit": "usd",
                "value": 14600112
            },
            {
                "label": "Maturities of investments",
                "concept": "ProceedsFromSaleOfShortTermInvestments",
                "unit": "usd",
                "value": 32173342
            },
            {
                "label": "Purchases of capital assets",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 5828137
            },
            {
                "label": "Proceeds from sale of intangible assets",
                "concept": "ProceedsFromSaleOfIntangibleAssets",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Purchase of intangible assets and other assets",
                "concept": "PaymentsToAcquireIntangibleAssets",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": 11745093
            },
            {
                "label": "Proceeds from sale of common stock",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 24100000
            },
            {
                "label": "Proceeds from stock option and warrant exercises, net of tax payments",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 865857
            },
            {
                "label": "Expenses from other financing activities",
                "concept": "PaymentsToMinorityShareholders",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 24926053
            },
            {
                "label": "Increase (decrease) in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": 4724165
            },
            {
                "label": "Common stock issued for purchase of intangible and other assets of Bioject",
                "concept": "ino:CommonStockIssuedForIntangibleAndOtherAssets",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Change in amounts accrued for purchases of property and equipment",
                "concept": "IncreaseDecreaseInOtherAccruedLiabilities",
                "unit": "usd",
                "value": 1185087
            }
        ],
        "ic": [
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -32565023
            },
            {
                "label": "Unrealized gain (loss) on investment in affiliated entity",
                "concept": "ino:OtherComprehensiveIncomeLossUnrealizedGainLossOnInvestmentInAffiliatedEntityNetOfTax",
                "unit": "usd",
                "value": -437708
            },
            {
                "label": "Unrealized gain on short-term investments",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": 290402
            },
            {
                "label": "Comprehensive loss attributable to Inovio Pharmaceuticals, Inc.",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -32712329
            },
            {
                "label": "Revenue under collaborative research and development arrangements",
                "concept": "LicensesRevenue",
                "unit": "usd",
                "value": 20646902
            },
            {
                "label": "Revenue under collaborative research and development arrangements with affiliated entity",
                "concept": "ino:LicenseFeeAndMilestoneRevenueFromAffiliatedEntity",
                "unit": "usd",
                "value": 410209
            },
            {
                "label": "Grants and miscellaneous revenue",
                "concept": "RevenueFromGrants",
                "unit": "usd",
                "value": 8037880
            },
            {
                "label": "Grants and miscellaneous revenue from affiliated entity",
                "concept": "ino:GrantAndMiscellaneousRevenueAffiliates",
                "unit": "usd",
                "value": 1693318
            },
            {
                "label": "Revenues:",
                "concept": "Revenues",
                "unit": "usd",
                "value": 30788309
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 48421255
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 13936695
            },
            {
                "label": "Gain on sale of assets",
                "concept": "GainLossOnDispositionOfAssets",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 62357950
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -31569641
            },
            {
                "label": "Interest and other income, net",
                "concept": "InterestAndOtherIncome",
                "unit": "usd",
                "value": 640362
            },
            {
                "label": "Change in fair value of common stock warrants, net",
                "concept": "ino:ChangeInFairValueOfCommonStockWarrants",
                "unit": "usd",
                "value": -196023
            },
            {
                "label": "Gain (loss) on investment in affiliated entity",
                "concept": "ino:ChangeInValueOfInvestmentsInAffiliatedCompany",
                "unit": "usd",
                "value": -1439721
            },
            {
                "label": "Net loss attributable to Inovio Pharmaceuticals, Inc.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -32565023
            },
            {
                "label": "Net loss per common share attributable to Inovio Pharmaceuticals, Inc. stockholders - basic and diluted ($ per share)",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.44
            },
            {
                "label": "Weighted average number of common shares outstanding used in per share calculations - basic and diluted (shares)",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 74783791
            }
        ]
    }
}